- Home
- SURG vs CRIS Comparison
SURG vs CRIS Comparison
Compare SURG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- CRIS
- Stock Information
- Founded
- SURG 2006
- CRIS 2000
- Country
- SURG United States
- CRIS United States
- Employees
- SURG N/A
- CRIS N/A
- Industry
- SURG Advertising
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SURG Consumer Discretionary
- CRIS Health Care
- Exchange
- SURG Nasdaq
- CRIS Nasdaq
- Market Cap
- SURG 56.5M
- CRIS 21.3M
- IPO Year
- SURG N/A
- CRIS 2000
- Fundamental
- Price
- SURG $3.16
- CRIS $2.32
- Analyst Decision
- SURG Strong Buy
- CRIS Strong Buy
- Analyst Count
- SURG 1
- CRIS 2
- Target Price
- SURG $9.00
- CRIS $16.50
- AVG Volume (30 Days)
- SURG 103.4K
- CRIS 71.8K
- Earning Date
- SURG 08-12-2025
- CRIS 07-31-2025
- Dividend Yield
- SURG N/A
- CRIS N/A
- EPS Growth
- SURG N/A
- CRIS N/A
- EPS
- SURG N/A
- CRIS N/A
- Revenue
- SURG $40,029,467.00
- CRIS $11,202,000.00
- Revenue This Year
- SURG $57.76
- CRIS N/A
- Revenue Next Year
- SURG $112.61
- CRIS $10.67
- P/E Ratio
- SURG N/A
- CRIS N/A
- Revenue Growth
- SURG N/A
- CRIS 14.17
- 52 Week Low
- SURG $1.05
- CRIS $1.02
- 52 Week High
- SURG $3.47
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- SURG 58.30
- CRIS 52.52
- Support Level
- SURG $2.64
- CRIS $2.11
- Resistance Level
- SURG $2.95
- CRIS $2.26
- Average True Range (ATR)
- SURG 0.21
- CRIS 0.21
- MACD
- SURG 0.03
- CRIS -0.04
- Stochastic Oscillator
- SURG 60.98
- CRIS 21.36
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.